BioCentury
ARTICLE | Clinical News

Regnite gabapentin enacarbil regulatory update

January 23, 2012 8:00 AM UTC

XenoPort and Astellas said the Japanese Ministry of Health, Labor and Welfare (MHLW) approved Regnite gabapentin enacarbil to treat moderate to severe restless legs syndrome (RLS). The approval trigge...